ApicHope Pharmaceutical Group (300723.SZ) expects a pre-loss for the year 2024, with a projected net loss of 472 million to 680 million yuan, turning from profit to loss.

ApicHope Pharmaceutical Group (300723.SZ) released its performance forecast for the year 2024, expecting a net loss attributable to the shareholders of the listed company of 4.72 billion to 6.8 billion yuan, turning from profit to loss. After deducting non-recurring gains and losses, the net loss is expected to be 2.41 billion to 3.47 billion yuan, turning from profit to loss.